The Effect of Quercetin on Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Beclin1, P62, and LC3: An Experimental Study
2024

Quercetin's Impact on Non-Alcoholic Fatty Liver Disease

Sample size: 47 publication 10 minutes Evidence: moderate

Author Information

Author(s): Katsaros Ioannis, Sotiropoulou Maria, Vailas Michail, Papachristou Fotini, Papakyriakopoulou Paraskevi, Grigoriou Marirena, Kostomitsopoulos Nikolaos, Giatromanolaki Alexandra, Valsami Georgia, Tsaroucha Alexandra, Schizas Dimitrios, Pintado Manuela, Campos Débora A.

Primary Institution: National and Kapodistrian University of Athens, Laikon General Hospital

Hypothesis

This study evaluates the impact of quercetin on NAFLD and assesses the roles of autophagy-related proteins in disease progression.

Conclusion

Quercetin effectively reduces NAFLD severity and modulates autophagy-related proteins.

Supporting Evidence

  • Quercetin-treated groups showed significant reductions in NAFLD Activity Score compared to controls.
  • Immunohistochemistry indicated increased expression of autophagy markers in quercetin groups.
  • Western blot analysis revealed significant elevations in LC3A in the treated groups.

Takeaway

Quercetin, a natural compound, helps make the liver healthier by reducing fat buildup and inflammation.

Methodology

Forty-seven male C57BL/6J mice were fed a high-fat diet for 12 weeks to induce NAFLD, followed by quercetin treatment for 4 weeks.

Limitations

The study was conducted in an experimental mouse model, and further research is needed to confirm these findings in humans.

Participant Demographics

Male C57BL/6J mice

Statistical Information

P-Value

0.011

Confidence Interval

95% CI: 0.01–0.69

Statistical Significance

p = 0.011

Digital Object Identifier (DOI)

10.3390/nu16244282

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication